FDA Approves First Cannabis-Based Epilepsy Drug

fda-logo

MARYLAND: The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from Read the full article…

WellSpan Prepares To Launch Region’s First Medical Marijuana Study

Two studies will test CBD on epilepsy: one for children with Dravet syndrome and one for those with Lennox–Gastaut syndrome.

PENNSYLVANIA:  At WellSpan Health, pediatric neurologist Dr. Todd Barron said about 50 percent of his patients have epilepsy. Medical marijuana isn’t a foreign topic, as anecdotal evidence suggests the CBD compound in the plant can help with seizures, he said. With no definite answer — yet — Barron said WellSpan will be conducting two studies Read the full article…

Georgia Boy Among First To Receive Experimental Medical Marijuana Drug

A 7-year-old boy is one of the first people in the country to receive a potent form of medical marijuana as part of a clinical trial to reduce seizures.

GEORGIA:  A 7-year-old boy is one of the first people in the country to receive a potent form of medical marijuana as part of an “extended use” clinical trial to reduce seizures. Preston Weaver, who lives in Athens, Georgia, has Lennox-Gastaut syndrome which is a severe form of epilepsy. He experiences up to 100 seizures a day, although many are Read the full article…